Research Progress in Extraction Technology and Biomedical Functions of Natural Sweeteners

What This Review Means for Formulators

If your product pipeline depends on sweeteners that are not sucrose, this paper gives you a useful map. It reviews how three natural sweeteners—allulose, fructooligosaccharides (FOS), and erythritol—are made, and what the research says about their production routes. For buyers and formulators, the value is not only in the ingredients. It is in the processing science behind them.

Background

The review was published in Frontiers in Nutrition under DOI: 10.3389/fnut.2022.952147. The Chinese title translates to "Research Progress on Extraction Technology and Biomedical Functions of Natural Sweeteners." The authors pull together recent work on extraction, purification, fermentation, and bioconversion. Their central question is practical: which production routes can deliver clean-label sweeteners at commercial scale without losing function?

Allulose gets special attention. It is a six-carbon rare ketohexose, and it is the C-3 epimer of D-fructose. That small structural change means the body does not metabolize it like regular sugar. It delivers almost zero calories. The review notes that biotransformation is becoming the main production strategy for allulose. That matters because enzyme-based conversion from fructose can fit into existing syrup processing lines.

What the Study Did

This was not a single lab experiment. It was a broad survey of published research. The authors examined extraction and purification methods for low-calorie sweeteners, then summarized what is known about their biomedical functions. They also looked at fermentation approaches for polyols and novel strains.

For FOS, they focused on membrane technology. They found that ultrafiltration (UF) combined with nanofiltration (NF), plus diafiltration, can concentrate and purify FOS from yacon. That is a practical result for manufacturers who need prebiotic fiber fractions without heat damage.

For erythritol, they highlighted fermentation with a newly isolated yeast strain, Clavispora lusitaniae JAR-1. Fermentation routes like this can produce high-purity non-sugar sweeteners and improve production efficiency.

Key Findings

The table below condenses the main production takeaways.

Sweetener	Production route	What the review reports
Allulose	Biotransformation from fructose	C-3 epimer of D-fructose; almost zero calories; biocatalysis is becoming dominant
FOS	Membrane filtration from yacon	UF + NF is a promising combination for concentration and purification
Erythritol	Fermentation by novel yeast	Clavispora lusitaniae JAR-1 enables high-purity production

Three things stand out. First, biotransformation is not a fringe method. For allulose, it is becoming the main path. Suppliers who use enzyme-based systems can scale with more confidence. Second, membrane filtration is a clean, thermal-free way to get FOS. Buyers who need label-friendly fibers should ask how the FOS was processed. Third, strain selection is everything for fermentation. A novel yeast can shift the economics.

What It Means for Manufacturers

Formulators should look at the sweetener's entire production story, not just its taste curve. Allulose made by biotransformation can fit low-calorie, no-sugar-added claims. Because it is a C-3 epimer, it behaves differently from fructose in the body. It also does real work in food systems, including browning and moisture retention. You still need to verify dosage and processing stability in your own application.

FOS from yacon using UF/NF gives you a way to deliver prebiotic fiber with mild sweetness. The membrane route avoids harsh conditions. That matters for clean-label positioning.

Erythritol made by fermentation with Clavispora lusitaniae JAR-1 is another option for tabletop sweeteners, bakery blends, and beverage systems. Ask suppliers about strain performance and purity. High-purity output lowers the risk of off-tastes and helps with tolerance thresholds, though your target consumer still decides the right dose.

One more point. The review groups biomedical functions with production technology. That is a reminder: production methods can change the biological profile of the finished ingredient. Extraction solvent, heat exposure, membrane pore size—none of these are neutral. They affect what ends up in the final product.

FAQ

What is the most important production trend in this review? Biotransformation is becoming the leading strategy for allulose. That is a shift away from chemical synthesis or plant extraction alone. For ingredient buyers, it means enzyme supply and process integration are the key levers.

Why should a formulator care about membrane filtration for FOS? Ultrafiltration combined with nanofiltration can purify FOS from yacon without high heat. The result is a cleaner prebiotic fiber with minimal process-induced loss.

Is erythritol from Clavispora lusitaniae JAR-1 ready for commercial use? The review presents it as a promising fermentation route. It can produce high-purity erythritol and improve efficiency. As with any novel strain, scale-up validation and regulatory approvals still apply.

The Real Conversation

Nobody buys a sweetener because of one paper. But this review gives you a useful scorecard. Allulose production is moving toward biotransformation. FOS purification is moving toward membranes. Erythritol production is improving through fermentation microbiology. The through-line is simple: processing choices shape ingredient performance. For anyone writing a specification or approving a supplier, that is worth keeping in front of you.